Oncology Institute Files 8-K on Financials
Ticker: TOIIW · Form: 8-K · Filed: Mar 27, 2024 · CIK: 1799191
| Field | Detail |
|---|---|
| Company | Oncology Institute, Inc. (TOIIW) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, company-update
TL;DR
Oncology Institute dropped an 8-K detailing its financials - check it out.
AI Summary
On March 27, 2024, The Oncology Institute, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. The company was formerly known as DFP Healthcare Acquisitions Corp. until January 8, 2020.
Why It Matters
This filing provides investors with crucial updates on the financial health and operational performance of The Oncology Institute, Inc.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- The Oncology Institute, Inc. (company) — Registrant
- DFP Healthcare Acquisitions Corp. (company) — Former company name
- March 27, 2024 (date) — Date of report
- January 8, 2020 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits for The Oncology Institute, Inc.
When was the company's name changed?
The company's name was changed from DFP Healthcare Acquisitions Corp. on January 8, 2020.
What is the state of incorporation for The Oncology Institute, Inc.?
The Oncology Institute, Inc. is incorporated in Delaware.
What is the business address of The Oncology Institute, Inc.?
The business address is 18000 Studebaker Rd, Suite 800, Cerritos, CA 90703.
What is the fiscal year end for The Oncology Institute, Inc.?
The fiscal year end for The Oncology Institute, Inc. is December 31.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-03-27 16:06:00
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 TOI The Nasdaq Stock Market LLC Redeem
- $11.50 — mon stock, each at an exercise price of $11.50 per share TOIIW The Nasdaq Stock Marke
Filing Documents
- toi-20240327.htm (8-K) — 29KB
- item991-q42023earningsrele.htm (EX-99.1) — 336KB
- image_0a.jpg (GRAPHIC) — 14KB
- 0001628280-24-013295.txt ( ) — 575KB
- toi-20240327.xsd (EX-101.SCH) — 2KB
- toi-20240327_def.xml (EX-101.DEF) — 16KB
- toi-20240327_lab.xml (EX-101.LAB) — 27KB
- toi-20240327_pre.xml (EX-101.PRE) — 16KB
- toi-20240327_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On March 27, 2024, The Oncology Institute, Inc. (the "Company") issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2023 and certain other financial information. A copy of the press release is furnished hereto as Exhibit 99.1, which is incorporated by reference herein. The information contained in Items 2.02 of this Current Report and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) The following exhibits are being filed herewith: Exhibit No. Description 99.1 Press release issued by The Oncology Institute, Inc. on March 27 , 20 24 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 27, 2024 The Oncology Institute, Inc. By: /s/ Mihir Shah Name: Mihir Shah Title: Chief Financial Officer